ArticleFrontiers in endocrinology2025
Study on the correlation between triglyceride glucose index, triglyceride glucose index to high-density lipoprotein cholesterol ratio, and the risk of diabetes in nonalcoholic fatty liver disease.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Nonalcoholic Fatty Liver Disease as a Risk Marker for Incident Type 2 Diabetes Mellitus: A Systematic Review.Cureus · 2026Review
- A sweet danger: the silent link between hyperinsulinemia and gastric cancer.Molecular cancer · 2026Review
- Association Between Metabolic and Atherogenic Indices and Circadian Blood Pressure Patterns in White-Coat Hypertension.Medicina (Kaunas, Lithuania) · 2026Article
- Association between triglyceride-glucose-related indices and liver-related events in patients with type 2 diabetes.Frontiers in endocrinology · 2026Article
- Association of TyG and TyG/HDL withFrontiers in medicine · 2026Article
- Beyond the triglyceride-glucose index, the cholesterol- high-density lipoprotein -glucose index as a superior predictor for diabetes risk in patients with major adverse cardiovascular events: dual evidence from the CHARLS database and real-world data.Frontiers in endocrinology · 2026Article
- Beyond HOMA-IR: Comparative Evaluation of Insulin Resistance and Anthropometric Indices Across Prediabetes and Type 2 Diabetes Mellitus in Metabolic Syndrome Patients.Life (Basel, Switzerland) · 2025Article
- Association of triglyceride-glucose index and remnant cholesterol levels with liver fibrosis progression and disease severity in patients with non-alcoholic fatty liver disease: a cross-sectional study.Frontiers in endocrinology · 2025Article
- Association between the total bilirubin to prothrombin time ratio index and diabetic retinopathy, nephropathy, peripheral neuropathy, and foot disease: a retrospective study and risk prediction model construction.Frontiers in endocrinology · 2025Article
- The correlation between the uric acid to high-density lipoprotein cholesterol ratio and stroke.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study seeks to investigate the association between the triglyceride-glucose index (TyG), triglyceride glucose index to high-density lipoprotein cholesterol ratio (TyG/HDL-c), and the risk of diabetes in individuals with nonalcoholic fatty liver disease (NAFLD). Methods: This retrospective study encompassed 457 NAFLD patients from The Central Hospital of Shaoyang, monitored over a three-year period. Missing data were addressed using multiple imputation, and the Synthetic Minority Over-sampling Technique (SMOTE) was employed to balance the dataset. Multicollinearity analysis was conducted to evaluate the collinearity among variables, while principal component analysis was utilized to examine the distribution of variables in both the original and balanced datasets. A multivariate logistic regression model was used to assess the association between TyG, TyG/HDL-c, and the risk of diabetes in NAFLD patients, adjusting for various covariates. Subgroup analysis was performed to identify differences across diverse populations, and restricted cubic splines (RCS) were used to explore potential non-linear relationships. The receiver operating characteristic (ROC) curve examined the diagnostic value of individual and combined indicators in assessing the risk of diabetes in NAFLD patients. Results: Upon adjustment for all covariates, TyG was found to significantly elevate the risk of diabetes among patients with NAFLD (OR = 1.96, 95% CI: 1.67-2.30, P < 0.001), with a notable non-linear relationship observed (threshold: 2.39, P-nonlinear = 0.002). Similarly, TyG/HDL-c significantly increased diabetes risk (OR = 1.90, 95% CI: 1.60-2.26, P < 0.001), also demonstrating a distinct non-linear association (threshold: 2.20, P-nonlinear < 0.001). Subgroup analyses revealed significant interactions between TyG and TyG/HDL-c across different gender subgroups (P for interaction < 0.05). The ROC curve analysis indicated that the combined use of TyG and TyG/HDL-c provided superior diagnostic performance for assessing diabetes risk in NAFLD patients (Area Under the Curve [AUC]: 0.703, 95% CI: 0.665-0.740), compared to the use of TyG (AUC: 0.694, 95% CI: 0.656-0.732) or TyG/HDL-c (AUC: 0.693, 95% CI: 0.655-0.731) independently. Conclusion: Both TyG and TyG/HDL-c are significantly associated with an increased risk of diabetes in NAFLD patients, exhibiting non-linear relationships. Furthermore, these associations vary significantly across gender subgroups, their combined use enhances risk assessment, supporting their clinical utility in evaluating diabetes risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.